Atika Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$17.4M |
| 2 |
Cogent Biosciences
COGT
|
+$14.2M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$12.1M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$12.1M |
| 5 |
HEICO Corp
HEI
|
+$8.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$85.5M |
| 2 |
Amazon
AMZN
|
+$72.5M |
| 3 |
Spotify
SPOT
|
+$43.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$43.2M |
| 5 |
Arista Networks
ANET
|
+$33.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.3% |
| 2 | Industrials | 20.32% |
| 3 | Consumer Discretionary | 9.92% |
| 4 | Technology | 9.36% |
| 5 | Communication Services | 5.34% |
Similar funds
Atika Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Atika Capital Management held 121 positions worth $950M, down 24% from $1.24B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Atika Capital Management withdrew a net $566M in Q4 2025, closing 44 positions and reducing 21 holdings. Its most notable exit was Microsoft, an estimated $85.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Atika Capital Management opened a new position in Madrigal Pharmaceuticals worth $19.8M.
- Atika Capital Management's largest Q4 2025 buy was Madrigal Pharmaceuticals: 34,000 shares worth $19.8M.
- Atika Capital Management added most to Teva Pharmaceuticals in Q4 2025, an estimated $12.1M increase.
- Atika Capital Management's biggest Q4 2025 reduction was Amazon, cutting an estimated $72.5M.
- Atika Capital Management fully exited Microsoft in Q4 2025, selling an estimated $85.5M.
- Atika Capital Management's ten largest holdings make up 47% of its $950M portfolio in Q4 2025.
- Atika Capital Management opened 35 new positions and closed 44 in Q4 2025.
- Atika Capital Management's portfolio value fell 24% quarter-over-quarter to $950M.
Based on Atika Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.